Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Invesco NASDAQ Biotech UCITS ETF (SBIO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
44.22 +0.85    +1.96%
21:17:40 - Real-time Data. Currency in USD ( Disclaimer )
  • Volume: 2,230
  • Bid/Ask: 44.14 / 44.27
  • Day's Range: 44.10 - 44.30
Type:  ETF
Market:  United Kingdom
Issuer:  Source
ISIN:  IE00BQ70R696 
SEDOL:  BQY79Y5
Asset Class:  Equity
Invesco NASDAQ Biotech 44.22 +0.85 +1.96%

SBIO Recent Sentiments

 
Information on users’ sentiments for the Invesco NASDAQ Biotech ETF, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Jun 12, 2023 medem Gazeta.pl   43.03 Nov 30, 2023 @ 39.37 -8.51%
May 17, 2023 Saša Hulman   42.84 Nov 30, 2023 @ 39.37 -8.10%
Mar 27, 2023 Paweł Kwas   41.59 Apr 21, 2023 @ 43.63 +4.91%
Jan 26, 2022 Jarek Jarek   41.47 Feb 18, 2022 @ 40.76 -1.71%
Nov 05, 2021 Tomasz Stępień   50.72 Nov 26, 2021 @ 49.47 -2.46%
Nov 03, 2021 Michał Zdziarski   52.28 Nov 26, 2021 @ 49.47 -5.37%
Oct 25, 2021 Radosław Peliński   50.47 Nov 19, 2021 @ 49.36 -2.20%
Oct 20, 2021 Marco Polo   50.45 Nov 12, 2021 @ 49.27 -2.34%
Oct 06, 2021 Jüri Teder   49.51 Oct 06, 2021 @ 49.90 +0.79%
Aug 31, 2021 Michał Michał   54.44 Sep 24, 2021 @ 54.34 -0.18%
Jun 08, 2021 Michał Michał   50.95 Jul 02, 2021 @ 52.90 +3.83%
Jun 02, 2021 René Piette   48.39 Jun 25, 2021 @ 52.12 -7.71%
Mar 09, 2021 Rowan Harley   47.82 Apr 02, 2021 @ 48.88 +2.22%
Mar 09, 2021 MIROSŁAW GROSZEK   47.65 Apr 02, 2021 @ 48.88 +2.58%
Feb 05, 2021 Odin Fairmile   53.68 Feb 26, 2021 @ 50.09 -6.69%
Jan 28, 2021 Piotr Galas   51.44 Feb 19, 2021 @ 53.70 +4.39%
Jan 25, 2021 Barbara Swystun   53.11 Feb 19, 2021 @ 53.70 +1.11%
Jan 14, 2021 rekrutacja handlowy   51.64 Feb 05, 2021 @ 53.74 +4.07%
Dec 29, 2020 Marek Gdynia   48.50 Dec 29, 2020 @ 48.50 0.00%
Nov 04, 2020 Wojciech Grzyb   44.20 Nov 27, 2020 @ 45.70 +3.39%
Sep 14, 2020 Eduardo Crespo   41.99 Oct 09, 2020 @ 45.55 +8.48%
Aug 20, 2020 Mariusz Ramsiewicz   42.83 Sep 11, 2020 @ 41.20 +3.81%
Jul 16, 2020 Tomasz Gargacz   45.61 Aug 07, 2020 @ 43.88 -3.79%
Jun 24, 2020 Remigiusz Gietrych   44.50 Jun 24, 2020 @ 44.50 0.00%
Jun 24, 2020 Remigiusz Gietrych   44.27 Jun 24, 2020 @ 44.20 -0.16%
Jun 23, 2020 Mariusz Ramsiewicz   44.50 Jul 17, 2020 @ 45.94 +3.24%
Apr 23, 2020 Michal Mrozowski   40.34 May 15, 2020 @ 41.88 +3.82%
Apr 14, 2020 Cristian Fontana   37.32 May 08, 2020 @ 40.80 +9.32%
Mar 05, 2020 Marco Colombo   38.04 Mar 12, 2020 @ 33.12 -12.93%
Dec 23, 2019 Cristian Fontana   39.14 Jan 17, 2020 @ 39.03 -0.28%
Nov 26, 2019 davide garulli   37.93 Dec 20, 2019 @ 38.93 -2.64%
Aug 27, 2019 olivier wagnon   32.85 Sep 20, 2019 @ 33.74 -2.71%
Jul 08, 2019 david martín galapero   34.84 Aug 02, 2019 @ 33.48 +3.90%
Feb 19, 2019 rafael S.G.   35.91 Mar 21, 2019 @ 36.09 +0.50%
Sep 13, 2018 david martín galapero   37.45 Oct 13, 2018 @ 34.16 -8.79%
Jul 26, 2018 Alexander Sikora   37.67 Aug 25, 2018 @ 37.55 -0.32%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SBIO Comments

Write your thoughts about Invesco NASDAQ Biotech UCITS ETF
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email